New treatment options for alcoholic hepatitis

Area of Science:

• Hepatology
• Gastroenterology
• Internal Medicine

Background:

• Alcoholic liver disease (ALD) burden is increasing globally.
• Alcoholic hepatitis (AH), a severe form of ALD, presents high morbidity and mortality.
• Current treatments for AH are limited, with steroids as the standard for select patients.

Purpose of the Study:

• To review the current landscape of alcoholic hepatitis treatment.
• To explore emerging therapeutic strategies for steroid-ineligible, intolerant, or unresponsive patients.
• To highlight the potential of novel approaches in managing AH.

Main Methods:

• Literature review of current and emerging treatments for alcoholic hepatitis.
• Analysis of pathophysiology, including gut microbiota, immune modulation, and genetic factors.
• Evaluation of liver transplantation and novel therapeutic avenues.

Main Results:

• Steroids are the current standard of care for severe AH but are not suitable for all patients.
• Liver transplantation offers short-term benefits but faces feasibility and ethical challenges.
• Emerging strategies include modulating gut microbiota, nutritional interventions, immune therapies, and enhancing hepatic regeneration.

Conclusions:

• There is a critical unmet need for effective treatments for patients with severe alcoholic hepatitis who cannot tolerate or respond to steroids.
• Investigating gut microbiota, immune responses, and regenerative medicine holds significant promise for future AH therapies.
• Advancements in "Omics" platforms are expected to accelerate the development of novel treatment options for alcoholic hepatitis soon.